AMGN
AMGN
NASDAQ · Biotechnology

Amgen Inc

S&P 500 Nasdaq 100 Dow Jones Mega-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks Best Dividend Stocks Highest Dividend Yield
$467.06
-1.05 (-0.22%)
As of Nov 12, 9:30 PM ET ·
Analyst Consensus
Hold
42
Analysts
Very High
Coverage
Buy 18 43%
Hold 20 48%
Sell 4 10%
Price Target
Analyst Price Target -59.1% upside
Low Target $141.50
Average Target $190.87
High Target $279.75
Current Price $467.06
Current
$467.06
Target
$190.87
$141.50 $190.87 avg $279.75
Scenario Analysis
Bear Case
$141.50
-69.7%
Low target
Base Case
$190.87
-59.1%
Avg target
Bull Case
$279.75
+-40.1%
High target
Risk/Reward
0.6x
Unfavorable
Price in Context
52-Week High
$483.99
-3.5% from high
52-Week Low
$302.13
+54.6% from low
50-Day SMA
$424.39
+10.1% vs SMA
200-Day SMA
$379.77
+23.0% vs SMA
RSI (14)
62.6
Neutral
Target vs 52W High
$190.87
-60.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
 Hold 42 43% $190.87 -59.1%
GILD
Gilead Sciences Inc
 Strong Buy 36 83% $362.68 +115.9%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 82% $438.34 -19.2%
MRNA
Moderna Inc
 Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
 Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
 Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
 Strong Buy 31 94% $114.11 -35.3%